On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.
From access to tests, treatments and vaccines for everyone to coordinating urgent action – Alex Harris shares five key messages ahead of the Coronavirus Global Response Summit.
As COVID-19 continues to spread around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.
By fully funding research and development for COVID-19 testing, treatment and vaccines we can reach COVID-Zero – no preventable deaths, no further lockdowns, no more disruption.
We’ve awarded £12 million, in partnership with DFID, to speed up global COVID-19 research and development and help low- and middle-income countries prepare. But more investment is needed.
Wellcome is supporting a step-change in COVID-19 testing by the UK government. Partners include the NHS, Public Health England, diagnostics companies Thermo Fisher Scientific, QIAGEN and Randox, UK universities, Boots, Royal Mail and Amazon.
The COVID-19 Therapeutics Accelerator is funding clinical trials that will answer whether the anti-malarial drugs hydroxychloroquine and chloroquine can be used to prevent the spread of COVID-19.
Now is not the time to make cautious investments: now is the time for courageous action to tackle COVID-19.
Following careful consideration of the rapidly changing COVID-19 pandemic, we’ve decided that the Wellcome Trust and Wellcome Collection buildings will begin a staggered closure to staff and visitors, and then remain closed until further notice.
Wellcome joins the Bill & Melinda Gates Foundation and Mastercard in launching a new initiative to speed the development of and access to therapies for COVID-19.
The COVID-19 outbreak is not just a public health crisis, it’s rapidly becoming a global crisis – of health, economics and politics.